59 Clinical Trials for: SEARCH[STUDY] GSK2118436, Page 1 of 3

Hide Studies Not Seeking New Volunteers

18

Dabrafenib and Lapatinib Ditosylate in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery

Condition(s): Poorly Differentiated Thyroid Gland Carcinoma; Recurrent Thyroid Gland Carcinoma; Stage IVA Thyroid Gland Follicular Carcinoma; Stage IVA Thyroid Gland Papillary Carcinoma; Stage IVB Thyroid Gland Follicular Carcinoma; Stage IVB Thyroid Gland Papillary Carcinoma; Stage IVC Thyroid Gland Follicular Carcinoma; Stage IVC Thyroid Gland Papillary Carcinoma; Thyroid Gland Adenocarcinoma; Thyroid Gland Medullary Carcinoma; Thyroid Gland Undifferentiated (Anaplastic) Carcinoma Last Updated: November 21, 2014Recruiting